Treatment of patent ductus arteriosus with ibuprofen

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 76, Issue 3, 1997, Pages

  Van Overmeire, Bart ^a   Follens, Ingrid ^a   Hartmann, Suzanne ^a   Creten, Wouter L ^b   Van Acker, Karel J ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Department of Biomedical Physics ^*

Author keywords

Doppler echocardiography; Ibuprofen; Indomethacin; Patent ductus arteriosus; Respiratory distress syndrome

Indexed keywords

CREATININE; IBUPROFEN LYSINE; INDOMETACIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; TREATMENT OUTCOME; URINE VOLUME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ADMINISTRATION SCHEDULE; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY, DOPPLER; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INJECTIONS, INTRAVENOUS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; URINATION;

EID: 0030764453     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.76.3.f179     Document Type: Article

References (42)

1. Clyman RI. Medical treatment of patent ductus arteriosus in premature infants. In: Long WA, ed. Fetal and Neonatal Cardiology. Philadelphia: WB Saunders, 1990:682-90.
2. Ellison RC, Peckham GJ, Lang P, Talner NS, Lerer TJ, Lin L. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983;71:364-72.
3. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus. J Pediatr 1978;93:647-51.
4. Stefano JL, Abbasi S, Pearlman SA, Spear ML, Esterly KL, Bhutani VK. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome; effects on pulmonary compliance and ventilation. Am Rev Respir Dis 1991;143:236-9.
5. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906.
6. Clyman RI. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies. J Pediatr 1996;128:601-7.
7. Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335:1491-5.
8. Van Bel F, Van de Bor M, Stijnen T, Baan J, Ruys JH. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics 1989;84:802-7.
9. Coombs RC, Morgan MEI, Durbin GM, Booth IW, McNeish AS. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990;65:1067-71.
10. Van Bel F, van Zoeren D, Schipper J, Guit GL, Baan J. Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants. J Pediatr 1990;116:965-70.
11. Van Bel F, Guit GL, Schipper J, van de Bor M, Baan J. Indomethacin-induced changes in renal bloodflow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 1991;118:621-6.
12. Wolf WM, Snover DC, Leonard AS. Localized intestinal perforation following intravenous indomethacin in premature infants. J Pediatr Surg 1989;24:409-10.
13. Friedman Z, Whitman V, Maisels MJ, Berman WJr, Marks KH, Vessell ES. Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants. J Clin Pharmacol 1978;18:272-9.
14. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 1982;306:506-10.
15. Cifuentes RF, Olley PM, Balfe JW, et al. Indumethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr 1979;95:583-7.
16. Seyberth HW, Rascher W, Hackenthal R, Wille L. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth weight infants with symptomatic ductus arteriosus. J Pediatr 1983;103:979-84.
17. Coceani F, White E, Bodach H, Olley PM. Age dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharmacol 1979;57:825-31.
18. Grosfeld JL, Kamman K, Gross K, Cikrit D, Ross D, Wolfe M. Comparative effects of indomethacine, Prostaglandine E1 and ibuprofen on bowel ischemia. Pediatr Surg 1983;18:738-42.
19. Chemtob S, Laudignon N, Beharry K, Rex J, Varma D, Wolfe L. Effects of prostaglandins and indomethacin on cerebral blood flow and oxygen consumption of conscious newborn piglets. Dev Pharmacol Ther 1990;14:1-14.
20. Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990;21:777-84.
21. Malcolm DD, Segar JL, Robillard E, Chemtob S. Indomethacin compromises hemodynamics during positive pressure ventilation, independently of prostanoids. J Appl Physiol 1993;74:1672-8.
22. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275:539-44.
23. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-9.
24. Aranda JV, Varvarigou N, Beharry K, Modanlou H, Bottolli I, Bardin C. Pharmacokinetics of intravenous ibuprofen in premature newborns. Pediatr Res 1994;35;81A.
25. Kauffman RE, Nelson MV Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr 1992;121:969-73.
26. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:6610-4.
27. Shankaran S, Slovis TLS, Bedard MP, Poland RL. Sonographic classification of intracranial hemorrhage: a prognostic indicator of mortality, morbidity and short-term neurologic outcome. J Pediatr 1982;100:469-75.
28. Shankaran S, Cepeda E, Muran G, Mariona F, Johnson S, Kazzi SN, et al. Antenatal phenobarbital therapy and neonatal outcome i: effect on intracranial hemorrhage. Pediatrics 1996;97:644-8.
29. Yeh TF, Wilks A, Singh J, Betkerur M, Lilien L, Phildes RS. Furosemide prevents renal side effects of indomethacin therapy in preterm infants with persistent ductus arteriosus. J Pediatr 1982;101:433-7.
30. Fajardo CA, Whyte RK, Steele BT. Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. J Pediatr 1992;121:771-5.
31. Rennie JM, Cooke RWI. Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child 1991;66:55-8.
32. Hammerman C, Aramburo MJ. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr 1990;117:771-6.
33. Sakhalkar VS, Merchant RH. Therapy of symptomatic patent ductus arteriosus in preterms using mefenemic acid and indomethacin. Indian Pediatr 1992;29:313-8.
34. Fujiwara T. Closure of PDA with mefenamic acid. In: Robertson B, Van Golde LMG, eds. Pulmonary surfactant. Amsterdam: Elsevier Science Publishers, 1984:495.
35. Van Overmeire B, Brus F, Van Acker KJ, Van Der Auwera JC, Schasfoort M, Elzenga NJ. Aspirin versus indomethacin treatment of patent ductus arteriosus in the preterm neonate with respiratory distress syndrome. Pediatr Res 1995;38:886-91.
36. Aranda JV, Varvarigou N, Beharry K, Modanlou H, Bardin C, Papageorgiou A. The effect of early intravenous ibuprofen on renal function in premature newborns. Pediatr Res 1994;37:361A.
37. Van Overmeire B, Follens I, Hartmann S, Mahieu L, Van Reempts P. Intravenous ibuprofen for the treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatr Res 1996;39:250A.
38. Patel J, Marks K, Roberts J, Azzopardi D, Edwards AD. Effect of indomethacin and ibuprofen on cerebral haemodynamics and oxygenation during treatment for patent ductus arteriosus (sPDA) in preterm infants. Pediatr Res 1995;38:448A.
39. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995;346:255.
40. Mosca F, Bray M, Lattanzio M, Fumagalli M, Colnaghi MR, Compagnoni G. Comparison of the effects of indomethacin (INDO) and ibuprofen (IBU) on cerebral perfusion and oxygenation in preterm infants. Pediatr Res 1996;39:231A.
41. Fowlie PW. Prophylactic indomethacin: systematic review and meta-analysis. Arch Dis Child 1996;74:F81-F7.
42. Gonzalez A, Sosenko IRS, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128:470-8.